Mycobacterium xenopi related spine infections: A case report and systematic literature review
Min Peng,Wei Li,Fengyi Li,Bo Tang,Yinhua Deng,Shuai Peng,Li Chen,Yingchun Dai
DOI: https://doi.org/10.1016/j.onehlt.2023.100502
IF: 9
2023-06-01
One Health
Abstract:Background and purpose: <i>Nontuberculous mycobacteria</i> (<i>NTM</i>) disease is an important infection disease throughout the world. <i>Mycobacterium xenopi</i> (<i>M. xenopi</i>) is a common <i>NTM</i>. Extrapulmonary infections due to <i>M. xenopi</i>, particularly spine infections, are a rare occurrence, but lack of research is cited as a constraint for implementing <i>NTM</i> control in such patients. The purposes of this paper are to describe a case of spondylodiscitis, to review the published literature on cases of <i>M. xenopi</i> spine infections, and to summarize the predisposing factors, diagnosis, and treatment of infection.Methods: A case of spondylodiscitis was caused by <i>M. xenopi</i> in a patient with systemic lupus erythematosus (SLE). Research was conducted using the PubMed, ScienceDirect, Embase, Wiley Online Library, and Scopus databases using the following search terms: "<i>Mycobacterium xenopi</i>", "vertebral", "spinal", "spondylodiscitis", "infection", and "osteomyelitis".Results: We retrieved 14 cases published before August 2022. The risk factors for infection were iatrogenic infections (3/14, 21.43%), SLE (4/14, 28.57%), AIDS (4/14, 28.57%), and immunocompetence without any comorbidities (3/14, 21.43%). The most common sites of infection were thoracic vertebrae (10/14, 71.43%) and lumbar vertebrae (4/14, 28.57%). A total of 14 cases were isolated and identified as <i>M. xenopi</i> from a toad by mycobacterial culture. The identification time was 55.00 ± 7.55 days (the present report identification time of metagenomic next generation sequencing (mNGS) was only 2 days). All patients were treated with antibiotic therapy, and the duration of treatment was 13.18 ± 2.13 months. Clarithromycin-based therapy showed a higher improvement rate (5/6, 83.33%). Surgical intervention was performed in 5 patients. Only 1 patient did not show any improvement after surgical treatment.Conclusion: <i>M. xenopi</i> spine infection in humans presents with atypical clinical symptoms. mNGS identification may be a good choice. <i>M. xenopi</i> may be considered in immunocompromised patients with spinal infection. We recommend a clarithromycin-containing regimen and prolonging the duration of treatment to ensure effectiveness.
infectious diseases,public, environmental & occupational health